BZI-ROCE

Benzinga Pro data, Avid Bioservices (NASDAQ:CDMO) reported Q4 sales of $39.80 million. Earnings fell to a loss of $309 thousand, resulting in a 167.03% decrease from last quarter. Avid Bioservices reached earnings of $461 thousand and sales of $38.02 million in Q3. Why Is ROIC Significant?...

Pulled from Benzinga Pro data, Energy Transfer (NYSE:ET) posted Q1 earnings of $1.45 billion, an increase from Q4 of 0.7%. Sales dropped to $19.00 billion, a 7.35% decrease between quarters. In Q4, Energy Transfer brought in $20.50 billion in sales but only earned $1.44 billion. Why Is ROCE...

According to Benzinga Pro, during Q4, Patterson Cos (NASDAQ:PDCO) earned $74.84 million, a 38.99% increase from the preceding quarter. Patterson Cos also posted a total of $1.72 billion in sales, a 7.5% increase since Q3. In Q3, Patterson Cos earned $53.85 million, and total sales reached $1.60...

Pulled from Benzinga Pro data, La-Z-Boy (NYSE:LZB) posted Q4 earnings of $34.65 million, an increase from Q3 of 9.72%. Sales dropped to $561.29 million, a 2.0% decrease between quarters. In Q3, La-Z-Boy brought in $572.72 million in sales but only earned $31.58 million. Why Is ROIC Significant?...

According to Benzinga Pro, during Q1, Wells Fargo (NYSE:WFC) earned $4.88 billion, a 85.69% increase from the preceding quarter. Wells Fargo also posted a total of $20.73 billion in sales, a 5.44% increase since Q4. In Q4, Wells Fargo earned $2.63 billion, and total sales reached $19.66 billion....

According to data from Benzinga Pro, during Q4, AMMO's (NASDAQ:POWW) reported sales totaled $43.68 million. Despite a 28.28% increase in earnings, the company posted a loss of $2.94 million. In Q3, AMMO brought in $38.71 million in sales but lost $4.10 million in earnings. What Is ROCE? Return on...

According to Benzinga Pro, during Q2, Coda Octopus Group (NASDAQ:CODA) earned $1.01 million, a 27.86% increase from the preceding quarter. Coda Octopus Group's sales decreased to $5.30 million, a 5.25% change since Q1. In Q1, Coda Octopus Group earned $1.40 million, and total sales reached $5.60...

According to Benzinga Pro, during Q4, Anterix (NASDAQ:ATEX) earned $15.54 million, a 293.79% increase from the preceding quarter. Anterix also posted a total of $608 thousand in sales, a 5.19% increase since Q3. In Q3, Anterix brought in $578 thousand in sales but lost $8.02 million in earnings....

According to Benzinga Pro, during Q4, Motorcar Parts of America (NASDAQ:MPAA) earned $1.46 million, a 42.2% increase from the preceding quarter. Motorcar Parts of America also posted a total of $194.73 million in sales, a 28.26% increase since Q3. Motorcar Parts of America earned $1.03 million, and...

Benzinga Pro data, Catalent (NYSE:CTLT) reported Q3 sales of $1.04 billion. Earnings fell to a loss of $227.00 million, resulting in a 380.25% decrease from last quarter. Catalent earned $81.00 million, and sales totaled $1.15 billion in Q2. What Is Return On Capital Employed? Earnings data...

Braze (NASDAQ:BRZE) brought in sales totaling $101.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 14.84%, resulting in a loss of $38.83 million. Braze collected $98.67 million in revenue during Q4, but reported earnings showed a $33.81 million loss....

According to Benzinga Pro data Concrete Pumping Holdings (NASDAQ:BBCP) posted a 13.7% decrease in earnings from Q1. Sales, however, increased by 15.19% over the previous quarter to $107.79 million. Despite the increase in sales this quarter, the decrease in earnings may suggest Concrete Pumping...

According to Benzinga Pro, during Q3, Vail Resorts (NYSE:MTN) earned $343.17 million, a 55.9% increase from the preceding quarter. Vail Resorts also posted a total of $1.24 billion in sales, a 12.34% increase since Q2. In Q2, Vail Resorts earned $220.12 million, and total sales reached $1.10...

According to Benzinga Pro data, during Q1, Root (NASDAQ:ROOT) posted sales of $70.10 million. Earnings were up 39.32%, but Root still reported an overall loss of $40.90 million. In Q4, Root brought in $71.30 million in sales but lost $67.40 million in earnings. Why Is ROCE Significant? Return on...

According to data from Benzinga Pro, during Q1, Vivos Therapeutics's (NASDAQ:VVOS) reported sales totaled $3.86 million. Despite a 72.03% increase in earnings, the company posted a loss of $1.70 million. In Q4, Vivos Therapeutics brought in $3.95 million in sales but lost $6.09 million in earnings...